TP53 and head and neck squamous cell carcinoma: We previously published that, in a cohort of 121 HNSCC patients collected at the IRCSS Regina Elena National Cancer Institute (Scientific Institutes of Hospitalization and Care), TP53 mutations were associated with a shorter recurrence-free survival (RFS) [17,19].